Literature DB >> 28554010

A bilaminated decellularized scaffold for islet transplantation: Structure, properties and functions in diabetic mice.

Xi Wang1, Kai Wang1, Wei Zhang1, Ming Qiang2, Ying Luo3.   

Abstract

Ectopic transplantation of islets provides a beta cell-replacement approach that may allow the recovery of physiological regulation of the blood sugar level in patients with Type I diabetes (T1D). In development of new extrahepatic islet transplantation protocols in support of the islet engraftment, it is pivotal to develop scaffold materials with multifaceted functions to provide beneficial microenvironment, mediate host response in favor of vascularization/islet integration and maintain long-term islet function at the transplantation site. In this study, a new composite bilaminar decellularized scaffold (CDS) was fabricated with differential structural, degradation and mechanical properties by the combination of a fast-degrading porous collagen matrix and a mechanically supportive porcine pericardium. When investigated in the epididymal fat pad in syngeneic mouse models, it was shown that CDS could serve as superior scaffolds to promote islet adhesion and viability, and islet-CDS constructs also allowed rapid reversal of the hyperglycemic condition in the host. The engraftment and effects of islets were achieved at low islet numbers, accompanied by minimal adverse tissue reactions and optimal islet integration with the surrounding fat tissue. The bioactive surface, mechanical/chemical durability and biocompatibility of the CDS may all have played important roles in facilitating the engraftment of islets. Our study provided new insights into scaffold's function in the interplay of cells, materials and host tissue and the extracellular matrix-based scaffolds have potential for clinical translation in the beta cell-replacement therapy to treat T1D.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Decellularized material; Hyperglycemia; Islet; Transplantation; Type I diabetes

Mesh:

Substances:

Year:  2017        PMID: 28554010     DOI: 10.1016/j.biomaterials.2017.05.033

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  15 in total

Review 1.  3D-Models of Insulin-Producing β-Cells: from Primary Islet Cells to Stem Cell-Derived Islets.

Authors:  Diana Ribeiro; Alexander J Kvist; Pernilla Wittung-Stafshede; Ryan Hicks; Anna Forslöw
Journal:  Stem Cell Rev Rep       Date:  2018-04       Impact factor: 5.739

Review 2.  Nanotechnology in cell replacement therapies for type 1 diabetes.

Authors:  Alexander U Ernst; Daniel T Bowers; Long-Hai Wang; Kaavian Shariati; Mitchell D Plesser; Natalie K Brown; Tigran Mehrabyan; Minglin Ma
Journal:  Adv Drug Deliv Rev       Date:  2019-02-02       Impact factor: 15.470

Review 3.  Engineering the vasculature for islet transplantation.

Authors:  Daniel T Bowers; Wei Song; Long-Hai Wang; Minglin Ma
Journal:  Acta Biomater       Date:  2019-05-23       Impact factor: 8.947

4.  A Collagen Based Cryogel Bioscaffold that Generates Oxygen for Islet Transplantation.

Authors:  Mehdi Razavi; Rosita Primavera; Bhavesh D Kevadiya; Jing Wang; Peter Buchwald; Avnesh S Thakor
Journal:  Adv Funct Mater       Date:  2020-02-20       Impact factor: 18.808

5.  A Safe, Fibrosis-Mitigating, and Scalable Encapsulation Device Supports Long-Term Function of Insulin-Producing Cells.

Authors:  Wanjun Liu; James A Flanders; Long-Hai Wang; Qingsheng Liu; Daniel T Bowers; Kai Wang; Alan Chiu; Xi Wang; Alexander U Ernst; Kaavian Shariati; Julia S Caserto; Benjamin Parker; Daqian Gao; Mitchell D Plesser; Lars G Grunnet; Claude Rescan; Rodrigo Pimentel Carletto; Louise Winkel; Juan M Melero-Martin; Minglin Ma
Journal:  Small       Date:  2021-12-13       Impact factor: 13.281

Review 6.  Emerging Theranostic Nanomaterials in Diabetes and Its Complications.

Authors:  Yuntao Liu; Siqi Zeng; Wei Ji; Huan Yao; Lin Lin; Haiying Cui; Hélder A Santos; Guoqing Pan
Journal:  Adv Sci (Weinh)       Date:  2021-11-25       Impact factor: 16.806

Review 7.  Can We Re-Engineer the Endocrine Pancreas?

Authors:  Antonio Citro; Harald C Ott
Journal:  Curr Diab Rep       Date:  2018-10-02       Impact factor: 4.810

8.  Effect of alginate matrix engineered to mimic the pancreatic microenvironment on encapsulated islet function.

Authors:  Kevin Enck; Riccardo Tamburrini; Chaimov Deborah; Carlo Gazia; Alec Jost; Fatma Khalil; Abdelrahman Alwan; Giuseppe Orlando; Emmanuel C Opara
Journal:  Biotechnol Bioeng       Date:  2020-12-25       Impact factor: 4.530

9.  A nanofibrous encapsulation device for safe delivery of insulin-producing cells to treat type 1 diabetes.

Authors:  Xi Wang; Kristina G Maxwell; Kai Wang; Daniel T Bowers; James A Flanders; Wanjun Liu; Long-Hai Wang; Qingsheng Liu; Chengyang Liu; Ali Naji; Yong Wang; Bo Wang; Jing Chen; Alexander U Ernst; Juan M Melero-Martin; Jeffrey R Millman; Minglin Ma
Journal:  Sci Transl Med       Date:  2021-06-02       Impact factor: 17.956

10.  A Zwitterionic Polyurethane Nanoporous Device with Low Foreign-Body Response for Islet Encapsulation.

Authors:  Qingsheng Liu; Xi Wang; Alan Chiu; Wanjun Liu; Stephanie Fuchs; Bo Wang; Long-Hai Wang; James Flanders; Yidan Zhang; Kai Wang; Juan M Melero-Martin; Minglin Ma
Journal:  Adv Mater       Date:  2021-08-06       Impact factor: 32.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.